Sustainability with Traceability Helps Secure
Brands and Their Global Supply Chains
Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in
Polymerase Chain Reaction (PCR)-based DNA manufacturing, and
American & Efird, (A&E), the world’s foremost thread
manufacturer, today announced A&E’s INTEGRITY™ advanced
identification thread technology is available for its ECO100
recycled sewing thread line. Utilizing Applied DNA Sciences’
CertainT® molecular-based technology, A&E’s introduction of
INTEGRITY™ ECO100, a sustainable and secure thread, provides an
innovative and economical solution for brands to authenticate and
validate their products anywhere within the supply chain by way of
a common component – sewing thread.
A&E’s INTEGRITY ECO100 identification thread line is
produced with 100% recycled fiber and combines the technology of
Applied DNA Sciences’ proprietary CertainT® with Beacon® platform.
This innovation can authenticate a brand’s products and components
by using the Beacon technology for a quick, in-the-field optical
verification and, when needed, by using a portable qPCR test for a
forensic analysis of the molecular tag.
Australian celebrity designer, Sara Caverley, will use A&E’s
ECO100 thread products, imbued with INTEGRITY and CertainT, in her
namesake footwear brand, CAVERLEY, to ensure supply chain security
and authenticity.
Ms. Caverley noted, “During my time as a designer, one of the
biggest lessons I’ve learned is the importance of supply chain
security. It is essential that CAVERLEY products are produced with
sustainable components that can be traced throughout their supply
chain while ensuring we are delivering the very best to our
customers. A&E’s ECO100 recycled sewing threads provide
tangible proof of the one-of-a-kind leather and luxury trimmings
used in our products.”
“Our customers are hyper-aware of the detrimental effects of
counterfeit products, from lost sales to the potential loss of
brand equity. It’s a real and global threat,” said Chris Alt,
Executive Vice President, A&E. “Our expansion of INTEGRITY
secure thread technology developed with Applied DNA Sciences is a
natural progression for us to address our customers’ needs and
extend our brand protection solutions.”
“INTEGRITY thread protects the brand, as well as supply chains,
at a time when security and sustainability are extremely important.
We are helping to ensure that customers can meet their supply chain
traceability and sustainability goals,” said Wayne Buchen, Vice
President, Strategic Sales, Applied DNA Sciences.
About CertainT
The CertainT® platform has three technology pillars (Tag, Test,
Track) which allows raw materials and products to be tagged with a
unique molecular identifier. This identifier can then be tested for
its presence as it travels throughout a global supply chain. All
the data points associated to tagging and testing are tracked by
uploading to a secure cloud database. The platform can be used
across industries such as textiles, cannabis, military, leather,
fertilizer, pharmaceuticals, personal care.
About Applied DNA Sciences
Applied DNA is commercializing LinearDNA™, its proprietary,
large-scale polymerase chain reaction (“PCR”)-based manufacturing
platform that allows for the large-scale production of specific DNA
sequences.
The LinearDNA platform has utility in the nucleic acid-based in
vitro diagnostics and preclinical nucleic acid-based drug
development and manufacturing market. The platform is used to
manufacture DNA for customers as components of in vitro diagnostic
tests and for preclinical nucleic acid-based drug development in
the fields of adoptive cell therapies (CAR T and TCR therapies),
DNA vaccines (anti-viral and cancer), RNA therapies, clustered
regularly interspaced short palindromic repeats (CRISPR) based
therapies, and gene therapies. Applied DNA has also established a
COVID-19 diagnostic and testing offering that is in the early
stages of commercialization and is grounded in the Company’s deep
expertise in DNA.
The LinearDNA platform also has non-biologic applications, such
as supply chain security, anti-counterfeiting and anti-theft
technology. Key end-markets include textiles, pharmaceuticals and
nutraceuticals, and cannabis, among others.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
The Company’s common stock is listed on NASDAQ under ticker
symbol ‘APDN,’ and its publicly traded warrants are listed on OTC
under ticker symbol ‘APPDW.’
Applied DNA is a member of the Russell Microcap® Index.
About A&E
A&E, a portfolio company of Elevate Textiles, is the
foremost manufacturer and distributor of premium quality industrial
and consumer sewing thread, embroidery thread and technical
textiles. Producers of apparel, automotive components, home
furnishings, medical supplies, footwear and a diverse range of
industrial products rely on A&E industrial sewing thread to
manufacture their products. Customers select A&E as the
preferred choice for industrial sewing thread, embroidery thread
and technical textiles because of A&E's dedication to providing
its customers with the finest products and services, at the highest
quality, delivered globally. Through its global network, A&E's
products are manufactured in 22 countries, distributed in 50
countries and sold in over 100 countries. In addition to A&E's
steadfast commitment to superior quality and customer service,
A&E is a recognized industry leader in environmental
sustainability and corporate social responsibility, and operates
its global facilities with the utmost regard for the safety and
health of its associates employed worldwide. A&E owns or
operates 28 manufacturing facilities and employs over 10,000
associates around the world directly or in partnership with joint
venture partners.
For more information, please visit amefird.com, and stay
connected with A&E on LinkedIn,
Facebook, and Twitter.
Forward Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934 and the Private Securities Litigation Reform Act of
1995. Forward-looking statements describe Applied DNA’s future
plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many
of which are beyond the control of Applied DNA. Actual results
could differ materially from those projected due to, its history of
net losses, limited financial resources, limited market acceptance,
the uncertainties inherent in research and development, our ability
to successfully enter into commercial contracts for the
implementation of our CertainT® platform, disruptions in the supply
of raw materials and supplies, and various other factors detailed
from time to time in Applied DNA’s SEC reports and filings,
including our Annual Report on Form 10-K filed on December 17, 2020
and our subsequent quarterly reports on Form 10-Q filed on February
11, 2021 and May 13, 2021, and other reports we file with the SEC,
which are available at www.sec.gov. Applied DNA undertakes no
obligation to update publicly any forward-looking statements to
reflect new information, events, or circumstances after the date
hereof or to reflect the occurrence of unanticipated events, unless
otherwise required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210608005066/en/
Investor contact: Sanjay M. Hurry, Applied DNA Sciences,
917.733.5573, sanjay.hurry@adnas.com Media contacts: APDN -
Stefania Catapano, GMLV - Scatapano@gmlv.co , A&E – Jacob
Blackburn, Jacob.Blackburn@elevatetextiles.com Web:
www.adnas.com, www.amefird.com Twitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Sep 2023 to Sep 2024